HEP PHARMA
Live / Applied — Non-final action mailed (as of 12 Nov 2025)
What this means for you
Not registered yet, but its 13 Jun 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79411704
- Mark type
- Word mark
- Filed
- 13 Jun 2024
- Attorney of record
- Gregory Golla
Goods and services
- Class 005 — Pharmaceuticals: Medicines for Hepatitis B, diabetes, non-alcoholic fatty liver disease, and hyperlipidemia; pharmaceutical preparations for the prevention of Hepatitis B, diabetes, non-alcoholic fatty liver disease, and hyperlipidemia; chemico-pharmaceutical preparations for the prevention of Hepatitis B, diabetes, non-alcoholic fatty liver disease, and hyperlipidemia; biological preparations for the treatment of Hepatitis B, diabetes, non-alcoholic fatty liver disease, and hyperlipidemia; medical preparations for slimming purposes; slimming pills; injectable medicinal solutions, namely, pharmaceuticals for treatment of Hepatitis B, diabetes, non-alcoholic fatty liver disease, and hyperlipidemia; biochemical medicines for Hepatitis B, diabetes, non-alcoholic fatty liver disease, and hyperlipidemia
Owner
Prosecution history
- 12 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Nov 2025 — NON-FINAL ACTION E-MAILED
- 12 Nov 2025 — NON-FINAL ACTION WRITTEN
- 18 Jul 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 18 Jul 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 18 Jul 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Feb 2025 — REFUSAL PROCESSED BY IB
- 22 Jan 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 22 Jan 2025 — REFUSAL PROCESSED BY MPU
- 25 Dec 2024 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 24 Dec 2024 — NON-FINAL ACTION WRITTEN
- 18 Dec 2024 — ASSIGNED TO EXAMINER
- 13 Dec 2024 — APPLICATION FILING RECEIPT MAILED
- 13 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 12 Dec 2024 — SN ASSIGNED FOR SECT 66A APPL FROM IB